Skip to main content

Table 1 Demographic, epidemiologic and clinical characteristics of different subtypes in patients with COVID-19

From: Clinical characteristics of different subtypes and risk factors for the severity of illness in patients with COVID-19 in Zhejiang, China

Characteristic

Mild type (n = 52)

Common type (n = 658)

Severe type (n = 61)

Critical type (n = 17)

Pvalue

Age (years)

37.5 (19.3–45.8)

45.0 (35.0–55.0)

55.0 (44.0–62.0)

70.0 (55.0–73.0)

< 0.001

Distribution

    

< 0.001

 ≤ 18

12 (23.1)

9 (1.4)

0 (0.0)

0 (0.0)

 

 19–40

16 (30.8)

241 (36.6)

11 (18.0)

0 (0.0)

 

 41–65

24 (46.2)

350 (53.2)

39 (63.9)

7 (41.2)

 

 ≥ 66

0 (0.0)

58 (8.8)

11 (18.0)

10 (58.8)

 

Sex (male)

26 (50.0)

329 (50.0)

39 (63.9)

13 (76.5)

0.034

BMI (kg/m2)

    

< 0.001

 <  18.5

5/25 (20.0)

20/370 (5.4)

0/36 (0.0)

0/13 (0.0)

 

 18.5–<  25

17/25 (68.0)

240/370 (64.9)

17/36 (47.2)

7/13 (53.8)

 

 ≥ 25

3/25 (12.0)

110/370 (29.7)

19/36 (52.8)

6/13 (46.2)

 

Current smoker

2 (3.8)

45 (6.8)

5 (8.2)

2 (11.8)

0.544

Exposure history in Wuhan

23 (44.2)

331 (50.3)

31 (50.8)

8 (47.1)

0.853

Incubation period (days)

7.0 (3.0–11.5) (n = 17)

6.0 (3.0–9.0) (n = 156)

3.0 (2.0–5.5) (n = 14)

7.0 (n = 1)

0.239

Family cluster

25 (48.1)

152 (23.1)

11 (18.0)

7 (41.2)

< 0.001

Time from illness onset to first hospital admission (days)

2.5 (1.0–4.0)

3.0 (1.0–6.0)

5.0 (2.0–8.0)

5.0 (2.5–6.5)

< 0.001

Coexisting disorder

 Any

10 (19.2)

161 (24.5)

31 (50.8)

16 (94.1)

< 0.001

 Hypertension

5 (9.6)

87 (13.2)

19 (31.1)

15 (88.2)

< 0.001

 Heart disease

0 (0.0)

9 (1.4)

1 (1.6)

1 (5.9)

0.254

 Diabetes

3 (5.8)

42 (6.4)

8 (13.1)

4 (23.5)

0.019

 Chronic obstructive pulmonary disease

0 (0.0)

0 (0.0)

2 (3.3)

1 (5.9)

0.001

 Cancer

0 (0.0)

3 (0.5)

3 (4.9)

0 (0.0)

0.030

 Chronic liver disease

1 (1.9)

26 (4.0)

2 (3.3)

2 (11.8)

0.351

 Chronic renal disease

0 (0.0)

5 (0.8)

1 (1.6)

1 (5.9)

0.150

Symptoms on admission

 Fever

28 (53.8)

534 (81.2)

57 (93.4)

17 (100.0)

< 0.001

 Cough

19 (36.5)

426 (64.7)

49 (80.3)

12 (70.6)

< 0.001

 Sputum production

8 (15.4)

219 (33.3)

29 (47.5)

9 (52.9)

0.001

 Hemoptysis

0 (0.0)

8 (1.2)

6 (9.8)

1 (5.9)

0.001

 Sore throat

8 (15.4)

95 (14.4)

7 (11.5)

1 (5.9)

0.796

 Nasal obstruction

6 (11.5)

41 (6.2)

0 (0.0)

0 (0.0)

0.034

 Myalgia

4 (7.7)

68 (10.3)

14 (23.0)

5 (29.4)

0.004

 Fatigue

10 (19.2)

105 (16.0)

18 (29.5)

6 (35.3)

0.013

Gastrointestinal symptom

7 (13.5)

63 (9.6)

12 (19.7)

6 (35.3)

0.002

Headache

2 (3.8)

61 (9.3)

11 (18.0)

1 (5.9)

0.076

  1. Data are presented as medians (interquartile ranges, IQR), n (%) and n/N (%)